283 related articles for article (PubMed ID: 20872942)
1. Surgical resection with hyperthermic intraperitoneal chemotherapy for gastric cancer patients with peritoneal dissemination.
Li C; Yan M; Chen J; Xiang M; Zhu ZG; Yin HR; Lin YZ
J Surg Oncol; 2010 Oct; 102(5):361-5. PubMed ID: 20872942
[TBL] [Abstract][Full Text] [Related]
2. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
[TBL] [Abstract][Full Text] [Related]
3. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.
Canbay E; Mizumoto A; Ichinose M; Ishibashi H; Sako S; Hirano M; Takao N; Yonemura Y
Ann Surg Oncol; 2014 Apr; 21(4):1147-52. PubMed ID: 24356799
[TBL] [Abstract][Full Text] [Related]
4. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Chua TC; Morris DL; Esquivel J
Ann Surg Oncol; 2010 May; 17(5):1330-6. PubMed ID: 20033321
[TBL] [Abstract][Full Text] [Related]
5. Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
Piso P; Slowik P; Popp F; Dahlke MH; Glockzin G; Schlitt HJ
Ann Surg Oncol; 2009 Aug; 16(8):2188-94. PubMed ID: 19408049
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center.
Yang XJ; Li Y; Yonemura Y
J Surg Oncol; 2010 May; 101(6):457-64. PubMed ID: 20401915
[TBL] [Abstract][Full Text] [Related]
7. Gene expression changes induced by HIPEC in a murine model of gastric cancer.
Graziosi L; Mencarelli A; Renga B; Santorelli C; Cantarella F; Bugiantella W; Cavazzoni E; Donini A; Fiorucci S
In Vivo; 2012; 26(1):39-45. PubMed ID: 22210714
[TBL] [Abstract][Full Text] [Related]
8. [Intraperitoneal chemotherapy in gastric cancer patients with peritoneal dissemination].
Hirono Y; Katayama K; Murakami M; Iida A; Yamaguchi A
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1404-9. PubMed ID: 16227738
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of intraperitoneal hyperthermic perfusion in far-advanced gastric cancer].
Kiuchi S; Fujimoto S; Shrestha RD; Kokubun M; Kobayashi K; Konno C; Takahashi M; Okui K
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2726-9. PubMed ID: 2506818
[TBL] [Abstract][Full Text] [Related]
10. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
Vaira M; Cioppa T; D'Amico S; de Marco G; D'Alessandro M; Fiorentini G; De Simone M
In Vivo; 2010; 24(1):79-84. PubMed ID: 20133981
[TBL] [Abstract][Full Text] [Related]
11. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma.
Fujimoto S; Takahashi M; Mutou T; Kobayashi K; Toyosawa T
Cancer; 1999 Feb; 85(3):529-34. PubMed ID: 10091726
[TBL] [Abstract][Full Text] [Related]
12. Feasibility study of postoperative intraperitoneal hyperthermochemotherapy by radiofrequency capacitive heating system for advanced gastric cancer with peritoneal seeding.
Mochiki E; Shioya M; Sakurai H; Andoh H; Ohno T; Aihara R; Asao T; Kuwano H
Int J Hyperthermia; 2007 Sep; 23(6):493-500. PubMed ID: 17952763
[TBL] [Abstract][Full Text] [Related]
13. Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis.
Lim SJ; Cormier JN; Feig BW; Mansfield PF; Benjamin RS; Griffin JR; Chase JL; Pisters PW; Pollock RE; Hunt KK
Ann Surg Oncol; 2007 Aug; 14(8):2309-18. PubMed ID: 17541691
[TBL] [Abstract][Full Text] [Related]
14. Survival of gastric cancer with concomitant liver metastases.
Kwok CM; Wu CW; Lo SS; Shen KH; Hsieh MC; Lui WY
Hepatogastroenterology; 2004; 51(59):1527-30. PubMed ID: 15362793
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study.
Yonemura Y; de Aretxabala X; Fujimura T; Fushida S; Katayama K; Bandou E; Sugiyama K; Kawamura T; Kinoshita K; Endou Y; Sasaki T
Hepatogastroenterology; 2001; 48(42):1776-82. PubMed ID: 11813623
[TBL] [Abstract][Full Text] [Related]
16. Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience.
Scaringi S; Kianmanesh R; Sabate JM; Facchiano E; Jouet P; Coffin B; Parmentier G; Hay JM; Flamant Y; Msika S
Eur J Surg Oncol; 2008 Nov; 34(11):1246-52. PubMed ID: 18222622
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermic peritoneal perfusion combined with anticancer chemotherapy as prophylactic treatment of peritoneal recurrence of gastric cancer.
Kaibara N; Hamazoe R; Iitsuka Y; Maeta M; Koga S
Hepatogastroenterology; 1989 Apr; 36(2):75-8. PubMed ID: 2499527
[TBL] [Abstract][Full Text] [Related]
18. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M
Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
[TBL] [Abstract][Full Text] [Related]
19. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
